Cholesterol biosensors represent a critical advancement in analytical technology, offering rapid, cost-effective and highly sensitive methods for the quantification of cholesterol in both clinical and ...

The broader shift is toward forecasting rather than reacting. Instead of detecting disease only after it crosses a threshold, systems will track trends that indicate future risk. The value of next ...

Particle size characterization in nanosuspensions often focuses on ‘majority’ features of the size distribution. Yet, for various suspensions in (bio)pharmaceuticals or fine chemicals, small fractions ...

Limit of detection (LOD) issues are ubiquitous in exposure assessment. Although there is an extensive literature on modeling exposure data under such imperfect measurement processes, including ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

Regulating PFAS: Detection and Evolving Limits PFAS is routinely quantified through liquid chromatography (HPLC) coupled to triple quadrupole (TQ) mass spectrometers. Multiple regulations and legal ...